Angiogenesis PET Using Radiolabeled RGD Peptides View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2010

AUTHORS

Keon Wook Kang , Jae Min Jeong , Ambros J. Beer

ABSTRACT

Angiogenesis, the process of developing a new vessel, is an essential feature of the growth of solid tumors. For decades, the targeting of tumor angiogenesis has evolved into one of the most widely pursued therapeutic strategies in cancer research. Antiangiogenic drugs like bevaci-zumab, sunitinib, or sorafenib, were proved to be effective in many solid cancers such as colorectal cancer, renal cell carcinoma, hepatocelluar carcinoma, etc. But, these kinds of molecular targeted therapy are responsive only in selected patient population. More... »

PAGES

195-211

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-3-540-93909-2_12

DOI

http://dx.doi.org/10.1007/978-3-540-93909-2_12

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1010718679


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kang", 
        "givenName": "Keon Wook", 
        "id": "sg:person.0761746266.86", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0761746266.86"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.31501.36", 
          "name": [
            "Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jeong", 
        "givenName": "Jae Min", 
        "id": "sg:person.01301360400.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01301360400.94"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Nuclearmedizinische Klinik, Technische Universit\u00e4t M\u00fcnchen, M\u00fcnchen, Germany", 
          "id": "http://www.grid.ac/institutes/grid.6936.a", 
          "name": [
            "Nuclearmedizinische Klinik, Technische Universit\u00e4t M\u00fcnchen, M\u00fcnchen, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Beer", 
        "givenName": "Ambros J.", 
        "id": "sg:person.0702550110.49", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0702550110.49"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2010", 
    "datePublishedReg": "2010-01-01", 
    "description": "Angiogenesis, the process of developing a new vessel, is an essential feature of the growth of solid tumors. For decades, the targeting of tumor angiogenesis has evolved into one of the most widely pursued therapeutic strategies in cancer research. Antiangiogenic drugs like bevaci-zumab, sunitinib, or sorafenib, were proved to be effective in many solid cancers such as colorectal cancer, renal cell carcinoma, hepatocelluar carcinoma, etc. But, these kinds of molecular targeted therapy are responsive only in selected patient population.", 
    "editor": [
      {
        "familyName": "Fanti", 
        "givenName": "Stefano", 
        "type": "Person"
      }, 
      {
        "familyName": "Farsad", 
        "givenName": "Mohsen", 
        "type": "Person"
      }, 
      {
        "familyName": "Mansi", 
        "givenName": "Luigi", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-3-540-93909-2_12", 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-3-540-93908-5", 
        "978-3-540-93909-2"
      ], 
      "name": "PET-CT Beyond FDG A Quick Guide to Image Interpretation", 
      "type": "Book"
    }, 
    "keywords": [
      "renal cell carcinoma", 
      "colorectal cancer", 
      "cell carcinoma", 
      "patient population", 
      "antiangiogenic drugs", 
      "hepatocelluar carcinoma", 
      "solid cancers", 
      "therapeutic strategies", 
      "solid tumors", 
      "tumor angiogenesis", 
      "new vessels", 
      "carcinoma", 
      "cancer", 
      "cancer research", 
      "angiogenesis", 
      "sunitinib", 
      "sorafenib", 
      "therapy", 
      "tumors", 
      "RGD peptide", 
      "drugs", 
      "vessels", 
      "PET", 
      "targeting", 
      "population", 
      "peptides", 
      "strategies", 
      "decades", 
      "features", 
      "growth", 
      "research", 
      "essential features", 
      "process", 
      "kind"
    ], 
    "name": "Angiogenesis PET Using Radiolabeled RGD Peptides", 
    "pagination": "195-211", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1010718679"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-3-540-93909-2_12"
        ]
      }
    ], 
    "publisher": {
      "name": "Springer Nature", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-3-540-93909-2_12", 
      "https://app.dimensions.ai/details/publication/pub.1010718679"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2022-10-01T07:01", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/chapter/chapter_91.jsonl", 
    "type": "Chapter", 
    "url": "https://doi.org/10.1007/978-3-540-93909-2_12"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-3-540-93909-2_12'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-3-540-93909-2_12'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-3-540-93909-2_12'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-3-540-93909-2_12'


 

This table displays all metadata directly associated to this object as RDF triples.

120 TRIPLES      22 PREDICATES      59 URIs      52 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-3-540-93909-2_12 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author Nd8e67f1671a445149f213dc44f7d7381
4 schema:datePublished 2010
5 schema:datePublishedReg 2010-01-01
6 schema:description Angiogenesis, the process of developing a new vessel, is an essential feature of the growth of solid tumors. For decades, the targeting of tumor angiogenesis has evolved into one of the most widely pursued therapeutic strategies in cancer research. Antiangiogenic drugs like bevaci-zumab, sunitinib, or sorafenib, were proved to be effective in many solid cancers such as colorectal cancer, renal cell carcinoma, hepatocelluar carcinoma, etc. But, these kinds of molecular targeted therapy are responsive only in selected patient population.
7 schema:editor Na52d0522d16d4ea28d5f38e5ecd4b249
8 schema:genre chapter
9 schema:isAccessibleForFree false
10 schema:isPartOf N98ea018344d84c36b53d4b6610a88caf
11 schema:keywords PET
12 RGD peptide
13 angiogenesis
14 antiangiogenic drugs
15 cancer
16 cancer research
17 carcinoma
18 cell carcinoma
19 colorectal cancer
20 decades
21 drugs
22 essential features
23 features
24 growth
25 hepatocelluar carcinoma
26 kind
27 new vessels
28 patient population
29 peptides
30 population
31 process
32 renal cell carcinoma
33 research
34 solid cancers
35 solid tumors
36 sorafenib
37 strategies
38 sunitinib
39 targeting
40 therapeutic strategies
41 therapy
42 tumor angiogenesis
43 tumors
44 vessels
45 schema:name Angiogenesis PET Using Radiolabeled RGD Peptides
46 schema:pagination 195-211
47 schema:productId N54331a4067d14504a652c50ad9ee53a5
48 Nd2630e233a214494bdbce6a3898f90d2
49 schema:publisher Ne697c12f4a7b452baae459eccdf894da
50 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010718679
51 https://doi.org/10.1007/978-3-540-93909-2_12
52 schema:sdDatePublished 2022-10-01T07:01
53 schema:sdLicense https://scigraph.springernature.com/explorer/license/
54 schema:sdPublisher N6b7d1166ac0943ff8c6564ad30fb1ab7
55 schema:url https://doi.org/10.1007/978-3-540-93909-2_12
56 sgo:license sg:explorer/license/
57 sgo:sdDataset chapters
58 rdf:type schema:Chapter
59 N100e9ec811b84e05840bb4922e90cc2f schema:familyName Mansi
60 schema:givenName Luigi
61 rdf:type schema:Person
62 N420cde48cf2446ef82871889f06f4ffc rdf:first sg:person.0702550110.49
63 rdf:rest rdf:nil
64 N54331a4067d14504a652c50ad9ee53a5 schema:name dimensions_id
65 schema:value pub.1010718679
66 rdf:type schema:PropertyValue
67 N577552b1de7246f7881fe6f2873a482f rdf:first Naa66273284c34777be3c3cc42eb2f525
68 rdf:rest Nf0a8ff6494fe4afb946486c7549e4357
69 N5dc8721f93b146d091a0993fe5ac16f4 rdf:first sg:person.01301360400.94
70 rdf:rest N420cde48cf2446ef82871889f06f4ffc
71 N6b7d1166ac0943ff8c6564ad30fb1ab7 schema:name Springer Nature - SN SciGraph project
72 rdf:type schema:Organization
73 N98ea018344d84c36b53d4b6610a88caf schema:isbn 978-3-540-93908-5
74 978-3-540-93909-2
75 schema:name PET-CT Beyond FDG A Quick Guide to Image Interpretation
76 rdf:type schema:Book
77 Na52d0522d16d4ea28d5f38e5ecd4b249 rdf:first Nf9f4984998c94002879dfbb6ba6b73a4
78 rdf:rest N577552b1de7246f7881fe6f2873a482f
79 Naa66273284c34777be3c3cc42eb2f525 schema:familyName Farsad
80 schema:givenName Mohsen
81 rdf:type schema:Person
82 Nd2630e233a214494bdbce6a3898f90d2 schema:name doi
83 schema:value 10.1007/978-3-540-93909-2_12
84 rdf:type schema:PropertyValue
85 Nd8e67f1671a445149f213dc44f7d7381 rdf:first sg:person.0761746266.86
86 rdf:rest N5dc8721f93b146d091a0993fe5ac16f4
87 Ne697c12f4a7b452baae459eccdf894da schema:name Springer Nature
88 rdf:type schema:Organisation
89 Nf0a8ff6494fe4afb946486c7549e4357 rdf:first N100e9ec811b84e05840bb4922e90cc2f
90 rdf:rest rdf:nil
91 Nf9f4984998c94002879dfbb6ba6b73a4 schema:familyName Fanti
92 schema:givenName Stefano
93 rdf:type schema:Person
94 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
95 schema:name Medical and Health Sciences
96 rdf:type schema:DefinedTerm
97 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
98 schema:name Oncology and Carcinogenesis
99 rdf:type schema:DefinedTerm
100 sg:person.01301360400.94 schema:affiliation grid-institutes:grid.31501.36
101 schema:familyName Jeong
102 schema:givenName Jae Min
103 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01301360400.94
104 rdf:type schema:Person
105 sg:person.0702550110.49 schema:affiliation grid-institutes:grid.6936.a
106 schema:familyName Beer
107 schema:givenName Ambros J.
108 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0702550110.49
109 rdf:type schema:Person
110 sg:person.0761746266.86 schema:affiliation grid-institutes:grid.31501.36
111 schema:familyName Kang
112 schema:givenName Keon Wook
113 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0761746266.86
114 rdf:type schema:Person
115 grid-institutes:grid.31501.36 schema:alternateName Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea
116 schema:name Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea
117 rdf:type schema:Organization
118 grid-institutes:grid.6936.a schema:alternateName Nuclearmedizinische Klinik, Technische Universität München, München, Germany
119 schema:name Nuclearmedizinische Klinik, Technische Universität München, München, Germany
120 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...